Tech lobbying groups file lawsuit against nation’s first digital advertising tax
Organizations representing tech titans like Google and Facebook claim the Maryland law represents “legislative overreach.”
Regulatory
Why marketing and communication will play a crucial role in Biden’s extended ACA enrollment period
The extra three months represent an opportunity to persuade as well as to educate.
Federal government pushes to ramp up vaccinations through new pharmacy program
Around 40,000 retail pharmacies are set to participate.
The path ahead for the FDA
In a Coalition for Healthcare Communication webinar, former FDA exec Nancy Bradish Myers reflected on the agency’s tumultuous 2020 and charted a path forward for 2021.
Health Policy 2021: COVID-19 pandemic, drug pricing, ACA reform and data privacy
Ending the pandemic is clearly the top public-health priority for the incoming Biden administration. Will action on drug pricing, ACA reform and data privacy follow?
“It’s always interesting when there’s a new administration and a new political configuration”
Washington healthcare policy insider Terry Haines offers his thoughts on COVID relief, the future of the Affordable Care Act and more.
Numerous groups are attempting to diversify COVID vaccine research
With communities of color historically underrepresented in clinical trials, numerous groups are working to diversify COVID-19 vaccine research.
FDA cracks down on e-cigarette makers that didn’t submit marketing applications
The agency sent warning letters to vape companies selling e-cigarettes without premarket authorization.
COVID-19 kicks drug pricing down the road
The attention to the upcoming presidential election also dims the likelihood of legislation efforts until 2021.
Pharma industry, Trump publicly negotiate drug pricing rules
President Trump is putting pressure on the pharma industry ahead of the presidential election.
Want to read more?
Please login or register first to view this content.
